Decrease of initial CD4+ T-cell counts at the time of diagnosis of HIV infection in Korea; 1988-2006

International Journal of STD and AIDS

Volumn 21, Issue 2, 2010, Pages 120-125

  Kee, M K ^a   Lee, J H ^a   Kim, G J ^a   Choi, B S ^a   Hong, K J ^a   Lee, J S ^a   Kim, S S ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

CD4+ T cell count; Epidemiology; HIV diagnosis; South Korea

Indexed keywords

CD4 ANTIGEN;

ADULT; AGE; ARTICLE; CD4 LYMPHOCYTE COUNT; DISEASE TRANSMISSION; FEMALE; GENDER; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; KOREA; MAJOR CLINICAL STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; RETROSPECTIVE STUDY;

ADULT; CD4 LYMPHOCYTE COUNT; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; REPUBLIC OF KOREA; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 75449097207     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/ijsa.2008.008405     Document Type: Article

References (31)

1. Volberding P. Clinical spectrum of HIV disease. In: Devita T, Hellman S, Rosenberg SA, eds. AIDS: Etiology, Diagnosis, Treatment and Prevention. 3rd edn. Philadelphia: Lippincott, 1992:123-40
2. Schneider MF, Gange SJ, Williams CM, et al. Patterns of the hazard of death after AIDS through the evolution of antiretroviral therapy: 1984-2004. AIDS 2005;19:2009-18
3. Takahashi Y. CD4+ count in resource-limited settings. UTH-JICA NEWSLETTER, HIV/AIDS & TB Control Project. January, 2004
4. Kim YB, Choi BS, Yang JM, Park YK, Shin YO. Normal immunological standard of Korean and its decrease curve in HIV infected persons. J Korean Soc Microbiol 1995;30:573-80
5. Dorrucci M, Rezza G, Porter K, Phillips A. Temporal trends in postseroconversion CD4 cell count and HIV load: the Concerted Action on Seroconversion to AIDS and Death in Europe Collaboration, 1985-2002. J Infect Dis 2007;195:525-34
6. Saag MS. Natural History of HIV disease. In: Broader S, Merigan TC Jr., Bolognesi D. eds. Text Book of AIDS Medicine. Baltimore: Williams & Wilkin, 1994:45-53
7. Bacchetti P, Moss AR. Incubation period of AIDS in San Francisco. Nature 1989;338:251-3
8. Fauci AS, Schnittman SM, Poli G, Koenig S, Pantaleo G. NIH conference. Immunopathogenic mechanisms in human immunodeficiency virus (HIV) infection. Ann Intern Med 1991;114:678-93
9. Giorgi JV, Fahey JL, Smith DC, et al. Early effects of HIV on CD4 lymphocytes in vivo. J Immunol 1987;138:3725-30
10. Hogg RS, Yip B, Chan KJ, et al. Rates of disease progression by baseline CD4 cell count and viral load after initiating triple-drug therapy. JAMA 2001;286:2568-77
11. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54
12. Stein DS, Korvick JA, Vermund SH. CD4+ lymphocyte cell enumeration for prediction of clinical course of human immunodeficiency virus disease: a review. J Infect Dis 1992;165:352-63
13. CD4+ T Lymphocyte Working Party Members of the General Haematology Task Force of BCSH. Guidelines for the enumeration of CD4+ T lymphocytes in immunosuppressed individuals. Clin Lab Haematol 1997;19:231-41
14. Feinberg MB. Changing the natural history of HIV disease. Lancet 1996;348:239-46
15. Schnittman SM, Lane HC, Greenhouse J, Justement JS, Baseler M, Fauci AS. Preferential infection of CD4+ memory T cells by human immunodeficiency virus type 1: evidence for a role in the selective T-cell functional defects observed in infected individuals. Proc Natl Acad Sci USA 1990;87:6058-62
16. Korean Center for Disease Control and Prevention, 2007. Guideline for HIV/AIDS. VII. The control of HIV/AIDS and support for HIV-infected individuals, KCDC, 2007
17. Castro KG, Ward JW, Slutsker L, Buehler JW, Jaffe HW, Berkelman RL. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep 1992;41:1-19
18. Dybul M, Fauci AS, Bartlett JG, Kaplan JE, Pau AK. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents. Recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm Rep 2002;51:1-55
19. Easterbrook PJ, Yu LM, Goetghebeur E, Boag F, McLean K, Gazzard B. Ten-year trends in CD4 cell counts at HIV and AIDS diagnosis in a London HIV clinic. AIDS 2000;14:561-71
20. Gupta SB, Gilbert RL, Brady AR, Livingstone SJ, Evans BG. CD4 cell counts in adults with newly diagnosed HIV infection: results of surveillance in England and Wales, 1990-1998. CD4 Surveillance Scheme Advisory Group. AIDS 2000;14:853-61
21. Dybul M, Bolan R, Condoluci D, et al. Evaluation of initial CD4+ T cell counts in individuals with newly diagnosed human immunodeficiency virus infection, by sex and race, in urban settings. J Infect Dis 2002;185:1818-21
22. Maini MK, Gilson RJ, Chavda N, et al. Reference ranges and sources of variability of CD4 counts in HIV-seronegative women and men. Genitourin Med 1996;72:27-31
23. Dorrucci M, Phillips AN, Longo B, Rezza G. Changes over time in post-seroconversion CD4 cell counts in the Italian HIV-Seroconversion Study: 1985-2002. AIDS 2005;19:331-5
24. Prins M, Robertson JR, Brettle RP, et al. Do gender differences in CD4 cell counts matter? AIDS 1999;13:2361-4
25. Shin YO, Jang YS, Hur SJ, Kim SS, Kee MK, Choi BS. Seroepidemiological study on human immunodeficiency virus infection in Korea. Natl Inst Health, Rep Korea 1993;30:163-72
26. Shin YO, Jang YS, Hur SJ, Kee MK, Kim SS, Choi BS. Seroepidemiological and Immunological Study on Human Immunodeficiency Virus (HIV) Infection in Korea. Natl Inst Health, Rep Korea 1994;31:212-22
27. Division of AIDS. Report of Human Immunodeficiency Virus/Sexually Transmitted Infections Surveillance. Korean Center for Disease Control and Prevention, 1999, Seoul, Korea
28. CASCADE Collaboration. Differences in CD4 cell counts at seroconversion and decline among 5739 HIV-1-infected individuals with well-estimated dates of seroconversion. J Acquir Immune Defic Syndr 2003;34:76-83
29. Healthy Living Project Team. Effects of a behavioral intervention to reduce risk of transmission among people living with HIV: the healthy living project randomized controlled study. J Acquir Immune Defic Syndr 2007;44:213-21
30. UNAIDS/WHO. UNSIDS/WHO Policy Statement on HIV Testing. 2004
31. Korea Centers for Disease Control and Prevention. Current Status and Control Policy of HIV/AIDS in Korea. Ninth International HIV/AIDS Symposium, New Strategies for HIV/STI Control, 2008